Champaign, IL, United States of America

Kenneth L Rinehart, Jr

This inventor holds 1 USPTO granted patent. Top assignee: The Upjohn Co.. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth L Rinehart, Jr. Retrieved from https://idiyas.com/inventor/kenneth-l-rinehart-jr-eaw5eees

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth L Rinehart, Jr: Innovator in Pharmaceutical Chemistry

Introduction

Kenneth L Rinehart, Jr. is a notable inventor based in Champaign, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has implications for antibiotic development and the enhancement of existing medications.

Latest Patents

Kenneth holds a patent for the "Acylation of tirandamycic, streptolic and sorbic acids to cephalosporin." This invention relates to the hybridization of streptolydigin, tirandamycin, and sorbic acid to penicillin and cephalosporin nuclei. His innovative approach has the potential to improve the efficacy of these important antibiotics.

Career Highlights

Throughout his career, Kenneth has been associated with The Upjohn Company, where he has applied his expertise in pharmaceutical research. His work has contributed to advancements in drug formulation and development, showcasing his commitment to improving healthcare outcomes.

Collaborations

Kenneth has collaborated with various professionals in the field, including his coworker Fritz Reusser. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Kenneth L Rinehart, Jr. is a distinguished inventor whose work in pharmaceutical chemistry has made a lasting impact. His innovative patent and collaborations highlight his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…